Fulcrum Therapeutics, Inc. (FULC)
10.10
+0.20
(+2.02%)
USD |
NASDAQ |
Feb 05, 11:32
Fulcrum Therapeutics EPS Diluted (Quarterly) : -0.313 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | -1.779 |
| Biogen, Inc. | 3.171 |
| CorMedix, Inc. | 1.259 |
| Apellis Pharmaceuticals, Inc. | 1.658 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.60M |
| Total Expenses (Quarterly) | 19.60M |
| Enterprise Value | 342.14M |
| Earnings Yield | -11.68% |
| Normalized Earnings Yield | -11.68 |